Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and marizomib

erlotinib hydrochloride has been researched along with marizomib in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010)
(erlotinib hydrochloride)		Studies
(marizomib)		Trials
(marizomib)		Recent Studies (post-2010) (marizomib)
4,3537863,033127464

Protein Interaction Comparison

ProteinTaxonomyerlotinib hydrochloride (IC50)marizomib (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.0013
Proteasome subunit alpha type-7Homo sapiens (human)0.0013
Proteasome subunit beta type-1Homo sapiens (human)0.144
Proteasome subunit alpha type-1Homo sapiens (human)0.0013
Proteasome subunit alpha type-2Homo sapiens (human)0.0013
Proteasome subunit alpha type-3Homo sapiens (human)0.0013
Proteasome subunit alpha type-4Homo sapiens (human)0.0013
Proteasome subunit beta type-8Homo sapiens (human)0.0013
Proteasome subunit beta type-9Homo sapiens (human)0.0013
Proteasome subunit alpha type-5Homo sapiens (human)0.0013
Proteasome subunit beta type-4Homo sapiens (human)0.0013
Proteasome subunit beta type-6Homo sapiens (human)0.0013
Proteasome subunit beta type-5Homo sapiens (human)0.0076
Proteasome subunit beta type-10Homo sapiens (human)0.0013
Proteasome subunit beta type-3Homo sapiens (human)0.0013
Proteasome subunit beta type-2Homo sapiens (human)0.0147
Proteasome subunit alpha type-6Homo sapiens (human)0.0013
Proteasome subunit alpha-type 8Homo sapiens (human)0.0013
Proteasome subunit beta type-7Homo sapiens (human)0.0013

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cusack, JC; Houston, M; Liu, R; Ljungman, D; Palladino, MA; Sloss, CM; Wang, F; Xia, L1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and marizomib

ArticleYear
Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Aug-15, Volume: 14, Issue:16

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Blotting, Western; Boronic Acids; Bortezomib; Cell Line, Tumor; Cetuximab; Deoxycytidine; ErbB Receptors; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Lactones; Mice; Mice, Nude; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Pyrroles; Quinazolines; Signal Transduction; Xenograft Model Antitumor Assays

2008